• Je něco špatně v tomto záznamu ?

Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides

B. Servusova-Vanaskova, P. Paterova, V. Garaj, J. Mandikova, J. Kunes, L. Naesens, P. Jílek, M. Dolezal, J. Zitko,

. 2015 ; 86 (4) : 674-681. [pub] 20150306

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc16028489

Grantová podpora
NT13346 MZ0 CEP - Centrální evidence projektů

This work presents synthesis and antimicrobial evaluation of nineteen 6-alkylamino-N-phenylpyrazine-2-carboxamides. Antimycobacterial activity was determined against Mycobacterium tuberculosis H37Rv, M. kansasii and two strains of M. avium. Generally, the antimycobacterial activity increased with prolongation of simple alkyl chain and culminated in compounds with heptylamino substitution (3e, 4e) with MIC = 5-10 μm against M. tuberculosis H37Rv. On the contrary, derivatives with modified alkyl chain (containing e.g. terminal methoxy or hydroxy group) as well as phenylalkylamino derivatives were mainly inactive. The most active compounds (with hexyl to octylamino substitution) were evaluated for their in vitro activity against drug-resistant strains of M. tuberculosis and possessed activity comparable to that of the reference drug isoniazid. None of the tested compounds were active against M. avium. Some derivatives exhibited activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (best MIC = 7.8 μm), while Gram-negative strains as well as tested fungal strains were completely unsusceptible. Active compounds were tested for in vitro toxicity on various cell lines and in most cases were non-toxic up to 100 μm.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc16028489
003      
CZ-PrNML
005      
20181212144211.0
007      
ta
008      
161005s2015 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1111/cbdd.12536 $2 doi
024    7_
$a 10.1111/cbdd.12536 $2 doi
035    __
$a (PubMed)25676890
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Servusová, Barbora $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 xx0230435
245    10
$a Synthesis and Antimicrobial Evaluation of 6-Alkylamino-N-phenylpyrazine-2-carboxamides / $c B. Servusova-Vanaskova, P. Paterova, V. Garaj, J. Mandikova, J. Kunes, L. Naesens, P. Jílek, M. Dolezal, J. Zitko,
520    9_
$a This work presents synthesis and antimicrobial evaluation of nineteen 6-alkylamino-N-phenylpyrazine-2-carboxamides. Antimycobacterial activity was determined against Mycobacterium tuberculosis H37Rv, M. kansasii and two strains of M. avium. Generally, the antimycobacterial activity increased with prolongation of simple alkyl chain and culminated in compounds with heptylamino substitution (3e, 4e) with MIC = 5-10 μm against M. tuberculosis H37Rv. On the contrary, derivatives with modified alkyl chain (containing e.g. terminal methoxy or hydroxy group) as well as phenylalkylamino derivatives were mainly inactive. The most active compounds (with hexyl to octylamino substitution) were evaluated for their in vitro activity against drug-resistant strains of M. tuberculosis and possessed activity comparable to that of the reference drug isoniazid. None of the tested compounds were active against M. avium. Some derivatives exhibited activity against Gram-positive bacteria including methicillin-resistant Staphylococcus aureus (best MIC = 7.8 μm), while Gram-negative strains as well as tested fungal strains were completely unsusceptible. Active compounds were tested for in vitro toxicity on various cell lines and in most cases were non-toxic up to 100 μm.
650    _2
$a zvířata $7 D000818
650    _2
$a antiinfekční látky $x chemická syntéza $x chemie $x farmakologie $7 D000890
650    _2
$a antifungální látky $x chemie $x farmakologie $7 D000935
650    _2
$a antituberkulotika $x chemická syntéza $x chemie $x farmakologie $7 D000995
650    _2
$a buněčné linie $x účinky léků $7 D002460
650    _2
$a techniky syntetické chemie $7 D060326
650    _2
$a preklinické hodnocení léčiv $x metody $7 D004353
650    _2
$a lidé $7 D006801
650    _2
$a methicilin rezistentní Staphylococcus aureus $x účinky léků $7 D055624
650    _2
$a mikrobiální testy citlivosti $7 D008826
650    _2
$a simulace molekulového dockingu $7 D062105
650    _2
$a Mycobacterium tuberculosis $x účinky léků $7 D009169
650    _2
$a vztahy mezi strukturou a aktivitou $7 D013329
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Paterová, Pavla $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. Department of Clinical Microbiology, University Hospital Hradec Králové, Sokolská 581, Hradec Králové, 500 05, Czech Republic. $7 xx0138094
700    1_
$a Garaj, Vladimír $u Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Comenius University, Odbojárov 10, Bratislava, 832 32, Slovakia. $7 _AN038040
700    1_
$a Mandíková, Jana $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 xx0159490
700    1_
$a Kuneš, Jiří, $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $d 1965- $7 xx0105105
700    1_
$a Naesens, Lieve $u Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, Leuven, 3000, Belgium.
700    1_
$a Jílek, Petr $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 mzk2002156737
700    1_
$a Doležal, Martin, $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $d 1961- $7 jn19981000714
700    1_
$a Zitko, Jan. $u Faculty of Pharmacy in Hradec Králové, Charles University in Prague, Heyrovského 1203, Hradec Králové, 500 05, Czech Republic. $7 xx0230408
773    0_
$w MED00173265 $t Chemical biology & drug design $x 1747-0285 $g Roč. 86, č. 4 (2015), s. 674-681
856    41
$u https://pubmed.ncbi.nlm.nih.gov/25676890 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20161005 $b ABA008
991    __
$a 20181212144335 $b ABA008
999    __
$a ok $b bmc $g 1166803 $s 953119
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2015 $b 86 $c 4 $d 674-681 $e 20150306 $i 1747-0285 $m Chemical biology & drug design $n Chem Biol Drug Des $x MED00173265
GRA    __
$a NT13346 $p MZ0
LZP    __
$a Pubmed-20161005

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...